^
BIOMARKER:

CDKN2A mutation

i
Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
CDKN2A mutation
Triple Negative Breast Cancer
atezolizumab
Sensitive
:
B
CDKN2A mutation
Breast Cancer
ribociclib
Resistant
:
B
CDKN2A mutation
Gallbladder Cancer
palbociclib
Resistant
:
C3
CDKN2A mutation
Clear Cell Renal Cell Carcinoma
palbociclib
Sensitive
:
C3
CDKN2A mutation
Pancreatic Cancer
palbociclib
Resistant
:
C3
CDKN2A mutation
Solid Tumor
Immunotherapy
Resistant
:
C3
CDKN2A mutation
Melanoma
Immunotherapy
Resistant
:
C3
CDKN2A mutation
Urothelial Cancer
Immunotherapy
Resistant
:
C3
CDKN2A mutation
Biliary Tract Cancer
toripalimab
Resistant
:
C3
CDKN2A mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive
:
C3
CDKN2A mutation
Penile Cancer
nivolumab
Sensitive
:
C4
CDKN2A mutation
Squamous Cell Carcinoma of Head and Neck
AZD1775 + VIC-1911
Sensitive
:
D
CDKN2A mutation
Non Small Cell Lung Cancer
AZD1775 + VIC-1911
Sensitive
:
D
CDKN2A mutation
Melanoma
palbociclib
Sensitive
:
D